Ekso Bionics Holdings Inc has a consensus price target of $6.25 based on the ratings of 7 analysis. The 3 most-recent analyst ratings were released by Lake Street, HC Wainwright & Co., and HC Wainwright & Co. on June 24, 2024, April 30, 2024, and March 5, 2024, respectively. With an average price target of $7.25 between Lake Street, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 610.78% upside for Ekso Bionics Holdings Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/24/2024 | Buy Now | 145.1% | Lake Street | Ben Haynor | → $2.5 | Initiates | → Buy | Get Alert |
04/30/2024 | Buy Now | 880.39% | HC Wainwright & Co. | Swayampakula Ramakanth | $9.25 → $10 | Maintains | Buy | Get Alert |
03/05/2024 | Buy Now | 806.86% | HC Wainwright & Co. | Swayampakula Ramakanth | $10 → $9.25 | Maintains | Buy | Get Alert |
01/22/2024 | Buy Now | 880.39% | HC Wainwright & Co. | Swayampakula Ramakanth | $9 → $10 | Maintains | Buy | Get Alert |
04/28/2023 | Buy Now | 782.35% | HC Wainwright & Co. | Swayampakula Ramakanth | → $9 | Reiterates | → Buy | Get Alert |
03/30/2023 | Buy Now | 782.35% | HC Wainwright & Co. | Swayampakula Ramakanth | → $9 | Reiterates | → Buy | Get Alert |
07/29/2022 | Buy Now | 782.35% | HC Wainwright & Co. | Swayampakula Ramakanth | $11 → $9 | Maintains | Buy | Get Alert |
The latest price target for Ekso Bionics Holdings (NASDAQ:EKSO) was reported by Lake Street on June 24, 2024. The analyst firm set a price target for $2.50 expecting EKSO to rise to within 12 months (a possible 145.10% upside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for Ekso Bionics Holdings (NASDAQ:EKSO) was provided by Lake Street, and Ekso Bionics Holdings initiated their buy rating.
There is no last upgrade for Ekso Bionics Holdings
There is no last downgrade for Ekso Bionics Holdings.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ekso Bionics Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ekso Bionics Holdings was filed on June 24, 2024 so you should expect the next rating to be made available sometime around June 24, 2025.
While ratings are subjective and will change, the latest Ekso Bionics Holdings (EKSO) rating was a initiated with a price target of $0.00 to $2.50. The current price Ekso Bionics Holdings (EKSO) is trading at is $1.02, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.